Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer

医学 放射外科 毒性 胰腺癌 放射治疗 前瞻性队列研究 腺癌 肿瘤科 癌症 放射科 核医学 内科学
作者
Albert C. Koong,Erin Christofferson,Quynh‐Thu Le,Karyn A. Goodman,Anthony D. Ho,Timothy Kuo,James M. Ford,George A. Fisher,Ralph S. Greco,Jeffrey A. Norton,George P. Yang
出处
期刊:International Journal of Radiation Oncology Biology Physics [Elsevier]
卷期号:63 (2): 320-323 被引量:313
标识
DOI:10.1016/j.ijrobp.2005.07.002
摘要

Purpose: To determine the efficacy of concurrent 5-fluorouracil (5-FU) and intensity-modulated radiotherapy (IMRT) followed by body stereotactic radiosurgery (SRS) in patients with locally advanced pancreatic cancer. Methods and Materials: In this prospective study, all patients (19) had pathologically confirmed adenocarcinoma and were uniformly staged. Our treatment protocol consisted of 45 Gy IMRT with concurrent 5-FU followed by a 25 Gy SRS boost to the primary tumor. Results: Sixteen patients completed the planned therapy. Two patients experienced Grade 3 toxicity (none had more than Grade 3 toxicity). Fifteen of these 16 patients were free from local progression until death. Median overall survival was 33 weeks. Conclusions: Concurrent IMRT and 5-FU followed by SRS in patients with locally advanced pancreatic cancer results in excellent local control, but does not improve overall survival and is associated with more toxicity than SRS, alone. Purpose: To determine the efficacy of concurrent 5-fluorouracil (5-FU) and intensity-modulated radiotherapy (IMRT) followed by body stereotactic radiosurgery (SRS) in patients with locally advanced pancreatic cancer. Methods and Materials: In this prospective study, all patients (19) had pathologically confirmed adenocarcinoma and were uniformly staged. Our treatment protocol consisted of 45 Gy IMRT with concurrent 5-FU followed by a 25 Gy SRS boost to the primary tumor. Results: Sixteen patients completed the planned therapy. Two patients experienced Grade 3 toxicity (none had more than Grade 3 toxicity). Fifteen of these 16 patients were free from local progression until death. Median overall survival was 33 weeks. Conclusions: Concurrent IMRT and 5-FU followed by SRS in patients with locally advanced pancreatic cancer results in excellent local control, but does not improve overall survival and is associated with more toxicity than SRS, alone.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
彭于晏应助四九采纳,获得30
1秒前
搞怪哑铃发布了新的文献求助10
1秒前
huang完成签到,获得积分10
1秒前
1秒前
雾予发布了新的文献求助10
2秒前
zyb945关注了科研通微信公众号
3秒前
3秒前
湘湘完成签到,获得积分10
5秒前
爱静静应助huang采纳,获得10
5秒前
7秒前
waa发布了新的文献求助10
7秒前
8秒前
张宇航发布了新的文献求助10
9秒前
yxx发布了新的文献求助10
10秒前
着急的语海完成签到,获得积分10
11秒前
科研通AI2S应助雾予采纳,获得10
12秒前
爆米花应助雾予采纳,获得10
12秒前
悦耳曼凝发布了新的文献求助10
14秒前
16秒前
自信筮发布了新的文献求助20
16秒前
allwind发布了新的文献求助80
17秒前
youtaixian完成签到 ,获得积分10
18秒前
yxx完成签到,获得积分10
18秒前
GlockieZhao完成签到,获得积分10
20秒前
21秒前
搜索v完成签到,获得积分10
22秒前
23秒前
nn关闭了nn文献求助
24秒前
cyl完成签到 ,获得积分10
25秒前
英俊的铭应助小廖采纳,获得10
26秒前
化学少女发布了新的文献求助10
26秒前
JamesPei应助科研通管家采纳,获得10
26秒前
深情安青应助科研通管家采纳,获得10
26秒前
充电宝应助科研通管家采纳,获得30
26秒前
Hello应助科研通管家采纳,获得10
26秒前
科研通AI2S应助科研通管家采纳,获得10
26秒前
慕青应助科研通管家采纳,获得10
26秒前
Orange应助科研通管家采纳,获得10
27秒前
科研通AI2S应助科研通管家采纳,获得10
27秒前
星辰大海应助科研通管家采纳,获得10
27秒前
高分求助中
Histotechnology: A Self-Instructional Text 5th Edition 2000
Rock-Forming Minerals, Volume 3C, Sheet Silicates: Clay Minerals 2000
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Encyclopedia of Computational Mechanics,2 edition 800
The Healthy Socialist Life in Maoist China 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3271071
求助须知:如何正确求助?哪些是违规求助? 2910337
关于积分的说明 8353679
捐赠科研通 2580842
什么是DOI,文献DOI怎么找? 1403756
科研通“疑难数据库(出版商)”最低求助积分说明 655922
邀请新用户注册赠送积分活动 635337